News
Canada's Sepset Biosciences Developing Point-of-Care Sepsis MDx With Eye Toward US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.
The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.
The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.
The recommendations, contained in a report to Congress, follow the GAO's inclusion of the HHS on its High-Risk List of government operations due to "persistent deficiencies in [its] ability to perform ...
NEW YORK – The US Food and Drug Administration has sent a warning letter to German diagnostics firm DRG Instruments alleging the company has sold two saliva-based cortisol tests in the US without the ...
The assay is intended to help with assessing HIV viral load levels that are used to monitor effectiveness of antiretroviral treatment.
The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.
NEW YORK – A tiny obstacle course for immune cells may someday help neonatal intensive care unit clinicians to quickly detect fatal bloodstream infections. Described recently in Pediatric Research, a ...
NEW YORK — Chicago-based academic health system Northwestern Medicine has struck a deal to collaborate with PathAI on its cloud-based AISight digital pathology image management system, the partners ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results